Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Illumina (ILMN)
NASDAQ:ILMN
Earnings Data
Report Date
May 01, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
0.96Last Year’s EPS
0.09Same Quarter Last Year
Moderate Buy
Based on 15 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 06, 2025
|% Change Since: -20.85%
|Next Earnings Date:May 01, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with notable achievements in revenue growth and strategic partnerships but also highlighted challenges, particularly in the China market and a decline in certain regional revenues.Company Guidance
During Illumina's fourth-quarter 2024 earnings call, the company provided guidance for 2025, anticipating low single-digit revenue growth on a constant currency basis and a non-GAAP operating margin of approximately 23%, improving by 170 basis points from 2024. Illumina expects diluted EPS to range between $4.50 and $4.65. The company highlighted significant progress in transitioning to the NovaSeq X platform, with 91 instruments placed during the quarter, bringing the installed base to 630, and consumables revenue growing by 2% year-over-year. Illumina aims to achieve 75% of high-throughput gigabases shipped on the NovaSeq X series by mid-2025, expecting this transition to drive further growth. Additionally, the company's strategic focus includes deepening customer collaboration, continuous innovation, and operational excellence, with $100 million in cost savings achieved in 2024 through manufacturing and logistics efficiencies. Despite geopolitical uncertainties in China, accounting for approximately 7% of global revenue, Illumina remains confident in its long-term strategy to achieve high single-digit revenue growth by 2027.Revenue Exceeds Expectations
Illumina delivered revenue of $1.1 billion in Q4 2024, exceeding expectations and reflecting approximately 1% growth from the prior year.
NovaSeq X Transition Success
The transition to NovaSeq X contributed significantly to revenue, with more than 65% of high-throughput gigabases shipped on the NovaSeq X series by the end of Q4 2024.
Operational Excellence and Cost Savings
Achieved over $100 million in cost savings across 2024 through greater manufacturing and logistics efficiencies.
Partnerships with Industry Leaders
Announced collaborations with NVIDIA and Truvera to enhance data analysis and expand genomic projects, respectively.
Strong Cash Flow
Cash flow provided by operations was $364 million in Q4 2024, contributing to a strong cash generation profile.
---
ILMN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
ILMN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 06, 2025 | $122.80 | $111.06 | -9.56% |
| Nov 04, 2024 | $153.49 | $154.96 | +0.96% |
| Aug 06, 2024 | $116.36 | $121.10 | +4.07% |
| May 02, 2024 | $120.50 | $114.61 | -4.89% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Illumina (ILMN) report earnings?
Illumina (ILMN) is schdueled to report earning on May 01, 2025, TBA Not Confirmed.
What is Illumina (ILMN) earnings time?
Illumina (ILMN) earnings time is at May 01, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ILMN EPS forecast?
ILMN EPS forecast for the fiscal quarter 2025 (Q1) is 0.96.
---
